Table 4.

Results of liver enzyme and function testing at the end of follow-up in non-alcoholic fatty liver disease/primary biliary cholangitis and primary biliary cholangitis alone patients

Test (normal range)	NAFLD/PBC (N = 68)		NAFLD (N = 136)		P value
	Mean ± SD	Median (IQR)	Mean ± SD	Median (IQR)
Follow-up (years)	6.6 ± 15.2	7.0 (3.6–8.8)	3.6 ± 2.6	3.0 (1.7–5.0)	0.001 a
ALT (<30 U/L)	34 ± 33	27 (19–40)	45 ± 37	35 (23–58)	0.008 a
AST (10–32 U/L)	33 ± 51	29 (22–40)	43 ± 51	32 (23–47)	0.13a
Albumin (33–45 g/L)	36 ± 4.4	37 (34–39)	38 ± 4.4	39 (36–41)	0.006
Total Bilirubin (3–19 µmol/L)	14.5 ± 45	7 (5.1–9)	8.6 ± 5.3	7 (6–9)	0.79a
INR (0.9–1.1)	0.99 ± 0.1	0.99; 0.9–1.0	1.11 ± 0.4	1.1 (0.93–1.1)	0.02 a

ALT, alanine aminotransferase; AST, aspartate aminotransferase; INR, international normalized ratio; IQR, interquartile range; NAFLD, non-alcoholic fatty liver disease; PBC, primary biliary cholangitis.

Bold indicates significant of P values.

^aNon-parametric tests.